Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$166.16 - $213.96 $692,721 - $891,999
-4,169 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$184.32 - $216.08 $236,113 - $276,798
1,281 Added 44.36%
4,169 $901,000
Q3 2021

Nov 10, 2021

SELL
$179.86 - $214.88 $75,900 - $90,679
-422 Reduced 12.75%
2,888 $533,000
Q2 2021

Aug 12, 2021

SELL
$170.47 - $211.93 $80,802 - $100,454
-474 Reduced 12.53%
3,310 $594,000
Q1 2021

May 14, 2021

SELL
$153.94 - $174.85 $289,099 - $328,368
-1,878 Reduced 33.17%
3,784 $633,000
Q4 2020

Feb 08, 2021

SELL
$101.87 - $151.79 $754,347 - $1.12 Million
-7,405 Reduced 56.67%
5,662 $859,000
Q3 2020

Nov 12, 2020

BUY
$99.9 - $121.13 $132,467 - $160,618
1,326 Added 11.29%
13,067 $1.32 Million
Q2 2020

Aug 11, 2020

BUY
$92.74 - $125.82 $404,068 - $548,197
4,357 Added 59.01%
11,741 $1.42 Million
Q1 2020

May 08, 2020

SELL
$79.39 - $115.35 $150,523 - $218,703
-1,896 Reduced 20.43%
7,384 $700,000
Q4 2019

Feb 12, 2020

BUY
$78.31 - $95.34 $292,879 - $356,571
3,740 Added 67.51%
9,280 $817,000
Q3 2019

Nov 12, 2019

SELL
$74.85 - $85.99 $1.11 Million - $1.28 Million
-14,843 Reduced 72.82%
5,540 $442,000
Q2 2019

Jul 30, 2019

BUY
$76.06 - $120.81 $114,013 - $181,094
1,499 Added 7.94%
20,383 $1.59 Million
Q1 2019

May 13, 2019

BUY
$107.15 - $126.84 $337,415 - $399,419
3,149 Added 20.01%
18,884 $2.22 Million
Q4 2018

Feb 08, 2019

BUY
$101.4 - $128.73 $691,142 - $877,423
6,816 Added 76.42%
15,735 $1.71 Million
Q3 2018

Nov 09, 2018

BUY
$113.81 - $129.46 $10,356 - $11,780
91 Added 1.03%
8,919 $1.14 Million
Q3 2018

Nov 07, 2018

BUY
$113.81 - $129.46 $115,175 - $131,013
1,012 Added 12.95%
8,828 $1.13 Million
Q2 2018

Aug 13, 2018

BUY
$101.14 - $118.31 $539,379 - $630,947
5,333 Added 214.78%
7,816 $886,000
Q1 2018

May 04, 2018

BUY
$107.21 - $151.94 $261,806 - $371,037
2,442 Added 5956.1%
2,483 $279,000
Q3 2017

Nov 09, 2017

BUY
$114.6 - $136.81 $4,698 - $5,609
41
41 $5,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.